We reach more than 65,000 registered users in Dec!! Register Now
Glycoscience fuels a new breed of cancer immunotherapy
- July 21, 2019
- 50 Views
- 0 Likes
- 0 Comment
Start-ups like Palleon and NextCure look to broaden the benefits of immuno-oncology with drugs that target a protein family called Siglecs and their glycan ligands
